American Vietnamese Biotech Incorporation (HNX:AMV)

Vietnam flag Vietnam · Delayed Price · Currency is VND
1,700.00
-100.00 (-5.56%)
At close: Apr 28, 2026
-15.00%
Market Cap 222.88B
Revenue (ttm) 154.07B
Net Income (ttm) -53.05B
Shares Out 131.11M
EPS (ttm) -405.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 387,557
Average Volume 340,877
Open 1,800.00
Previous Close 1,800.00
Day's Range 1,700.00 - 1,800.00
52-Week Range 1,700.00 - 2,800.00
Beta 0.93
RSI 48.96
Earnings Date May 5, 2026

About HNX:AMV

American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical diagnostic biological products in Vietnam. The company develops centralized testing centers; and provides medical machinery and equipment, and testing chemicals. It also offers sterilizers, drug labeling machines, medical image disc recorders, medical dry films, medical dry film printers, and digital radiology systems; lizer infrared therapy machines; infusion pumps and electric injection pumps; automatic molecular biology testing machines and automati... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 103
Stock Exchange Hanoi Stock Exchange
Ticker Symbol AMV
Full Company Profile

Financial Performance

In 2025, HNX:AMV's revenue was 154.07 billion, a decrease of -50.36% compared to the previous year's 310.35 billion. Losses were -53.05 billion, 374.0% more than in 2024.

Financial Statements

News

There is no news available yet.